TERMS OF REFERENCE
Development of the Rwanda Pharmaceutical Pricing Database
1. Background |
||||||||||
In recent years, the high prices of pharmaceutical products have posed challenges in both high- and low-income countries. In many instances, the high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted the healthcare system’s ability to provide population-wide access to essential medicines.
Pharmaceutical pricing policies must be carefully planned, implemented, and regularly reviewed and revised in response to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. The World Health Organization (WHO)'s 2020 guideline on country pharmaceutical pricing policies recognizes country experiences in managing the prices of pharmaceutical products.
The Rwanda Food and Drug Authority (Rwanda FDA), established in 2018, plays a crucial role in regulating the pharmaceutical market, encompassing pricing, procurement oversight, and supply chain governance. The agency aims to establish suitable administrative and technical mechanisms to prepare, implement, and monitor the pharmaceutical products pricing policy, established in 2020. While the regulatory framework is in place, the implementation tools to enforce and monitor the pricing policy are essential for its effective implementation and enforcement.
To address these needs, the World Health Organization (WHO) is supporting the Rwanda FDA to develop a pricing database to store pharmaceutical pricing data. This database will enhance regulatory oversight and support the effective enforcement of pricing policies.
The pharmaceutical pricing database will address this gap by providing the Rwanda FDA with a reliable platform for monitoring pricing trends, developing reference price lists, evaluating the impact of policies, and ensuring transparency in the pharmaceutical supply chain. Furthermore, this will strengthen efforts in developing pharmaceutical pricing policies and regulations, thereby increasing access to quality and safe medicines and vaccines.
Additionally, the pricing database will help contain public pharmaceutical expenses amid increasing demands on the Rwandan health system, partly due to economic growth, demographic transition, and increased burden of non-communicable diseases (NCDs).
In this regard, the WHO is seeking an IT company based in Rwanda with expertise in database design and development, including strong analytical and data management skills, preferably with experience in pharmaceutical pricing for three (3) months. |
||||||||||
2. Deliverables |
||||||||||
The selected company will perform the following activities, in collaboration with the RFDA and WHO: Inception phase and requirement gathering
Database development
Develop a user manual and hands-on training of the future users Develop a roadmap
Deliverables and Timelines are shown below:
|
||||||||||
3. Contract duration |
||||||||||
3months (October to December 2025) (2 months and ½, up to 31 Dec 2025) |
||||||||||
4. Requirements |
||||||||||
Educational Qualifications Members of the team should have at least Master’s degree in computer science, information technology, health informatics, or another relevant field such as medical sciences, project management, or economics, with a proven experience in data curation, monitoring and evaluation, accountability and learning, capacity building, and cybersecurity.
Experience Members of the company should have at least ten to fifteen years of experience in implementing solutions that enable health decision-makers to turn complex data into action, including in the African region.
Essential: the company should demonstrate the following:
Desirable:
Languages and level required
Proposal documents and submission (How to apply):
The consultancy firm will submit proposals which comprises the technical and financial details in PDF and/ or in Excel files. The technical proposal should be a narrative which includes the proposed approach, methodology and timeframe for each deliverable; Staffing structure, including staff CVs with completion certificates of research activities undertaken in the past if applicable. Details of days per team member articulated against a workplan of activities should be also included. The financial proposal includes activities and budget details. Interested firms shall submit their proposals with their full address to the following generic e-mail address for WHO/RWANDA: afwcorwbids@who.int The deadline for submission of proposal is 17 October 2025 at 23:59 PM, Kigali time.
Selection and contract signing After analysis of proposals WHO will notify the winner in writing and call for discussion, if necessary, followed by contract signing if fully agree. The work is expected to start immediately after contract signing. WHO Rwanda reserves the right to cancel any or all the proposal without assigning any reason thereof.
|